Association names lectureship award after lung cancer specialist
Click Here to Manage Email Alerts
International Association for the Study of Lung Cancer will name its Translational Research Lectureship Award after Fred R. Hirsch, MD, PhD.
The association, known as IASLC, confers lectureship awards each year at its annual World Conference on Lung Cancer. The awards honor individuals for their contributions to the field, their exemplary academic work and their service to IASLC.
“This honor will further solidify our recognition of Dr. Hirsch’s service to the IASLC over the past 40-plus years,” Dave Mesko, CEO of the association, said in a press release. “The over 8,000 members of the IASLC will see the Fred. R. Hirsch Lectureship Award for Translational Research as an understandable acknowledgment of the dedication that Fred has given to the lung cancer research community and to the IASLC.”
Hirsch — a longtime association member and its former CEO — is executive director of Center for Thoracic Oncology at Tisch Cancer Institute at Mount Sinai. He also is associate director of Tisch Cancer Institute, as well as Joe Low and Louis Price professor of medicine at Icahn School of Medicine at Mount Sinai.
The Translational Research Lectureship Award previously had been named for Adi Gazdar, MD, a pathologist and oncology researcher at UT Southwestern who died in 2018. The IASLC board voted to name its IASLC Merit Award for Gazdar in recognition of his legacy and lifelong contributions to the field.